Autor: "Lau IJ" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs.
Autorzy:: Gooding S; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom; MRC Human Immunology Unit, University of Oxford, Weatherall Institute of Molecular Medicine, Headley Way, Oxford, OX3 9DS, United Kingdom.
Lau IJ; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom.
Sheikh M; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom; Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford University Old Road Campus, Oxford, OX3 7LH, United Kingdom.
Roberts P; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom.
Wong J; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom.
Dickens E; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom.
Bullement A; BresMed Health Solutions, 84 Queen Street, North Church House, Sheffield, S1 2DW, United Kingdom.
Elvidge J; BresMed Health Solutions, 84 Queen Street, North Church House, Sheffield, S1 2DW, United Kingdom.
Lee D; BresMed Health Solutions, 84 Queen Street, North Church House, Sheffield, S1 2DW, United Kingdom.
Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, United Kingdom; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom; Royal Berkshire Hospital NHS Trust, London Rd, Reading, RG1 5AN, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Sep 14; Vol. 10 (9), pp. e0136207. Date of Electronic Publication: 2015 Sep 14 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cost-Benefit Analysis*
Antineoplastic Agents/*economics
Bortezomib/*economics
Multiple Myeloma/*economics
Thalidomide/*analogs & derivatives
Aged ; Antineoplastic Agents/therapeutic use ; Bortezomib/therapeutic use ; Female ; Humans ; Lenalidomide ; Male ; Middle Aged ; Multiple Myeloma/drug therapy ; Multiple Myeloma/epidemiology ; Recurrence ; Thalidomide/economics ; Thalidomide/therapeutic use ; United Kingdom

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Lau IJ"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język